Loading clinical trials...
Loading clinical trials...
Phase II Study of Combination Bortezomib, Dexamethasone, and Rituximab in Previously Untreated Patients With Waldenstrom's Macroglobulinemia: A Multicenter Trial of the European Myeloma Network
Conditions
Interventions
Bortezomib, Rituximab, Dexamethasone
Locations
4
Greece
Alexandra Hospital , Department of Clinical Therapeutics
Athens, Attica, Greece
Laikon Hospital
Athens, Attica, Greece
Erasmus Medical Center
Rotterdam, Netherlands
Hospital Universitario de Salamanca
Salamanca, Spain
Start Date
March 1, 2007
Primary Completion Date
November 1, 2010
Completion Date
November 1, 2015
Last Updated
April 30, 2021
NCT04274738
NCT01647971
NCT01125293
NCT00936611
NCT02363439
NCT00142116
Lead Sponsor
Meletios A. Dimopoulos
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions